ZCZi-Qi Chen

Zi-Qi Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zi-Qi Chen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Chenlan Xia

    Key Laboratory for Food Microbial Technology of Zhejiang Province, Zhejiang Gongshang University, Hangzhou, Zhejiang 310018, China

    1 shared publication
  • Chun-Yang Xu

    Department of Surgical Intensive Care Unit Shandong Provincial Hospital affiliated to Shandong First Medical University Jinan Shandong China

    1 shared publication
  • Fangtong Wei

    Key Laboratory for Food Microbial Technology of Zhejiang Province, Zhejiang Gongshang University, Hangzhou, Zhejiang 310018, China

    1 shared publication
  • Guo-Shan Ding

    Department of Liver Surgery and Organ Transplantation, Changzheng Hospital

    1 shared publication
  • Jiayi Fan

    Key Laboratory for Food Microbial Technology of Zhejiang Province, Zhejiang Gongshang University, Hangzhou, Zhejiang 310018, China

    1 shared publication
  • Junfeng Dong

    Organ Transplant Center Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University) Shanghai China

    1 shared publication

Latest Publications

  • Lactic acid bacteria target NF-κB signaling to alleviate gastric inflammation

    by Shiying Wu, Yuenuo Luo, Fangtong Wei, Yanan Li, Jiayi Fan, Yongqiang Chen, Wenjie Zhang, Xuelong Li, Yang Xu, Ziqi Chen, et al.

    L. plantarum ZJ316 treatment attenuated H. pylori-induced inflammation by suppressing NF-κB signaling and promoting beneficial changes in the gastric microbiota composition.


  • Open Access

    MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2

    by Chun-Yang Xu, Jun-Feng Dong, Zi-Qi Chen, Guo-Shan Ding, Zhi-Ren Fu

    MicroRNAs (miRNAs), a subgroup of small noncoding RNAs, play critical roles in tumor growth and metastasis. Accumulating evidence shows that the dysregulation of miRNAs is associated with the progression of hepatocellular carcinoma (HCC). However, the molecular mechanism by which miR-942-3p contributes to HCC remains undocumented. The association between miR-942-3p expression and the clinicopathological characteristics in HCC patients was analyzed by The Cancer Genome Atlas data set. The targets of miR-942-3p were identified by bioinformatic analysis and dual luciferase report assay. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Transwell assays were performed to assess the functional role of miR-942-3p in HCC cells. Consequently, we found that miR-942-3p expression level was elevated in HCC tissues and cell lines as compared with the normal tissues and was associated with the pathological stage and tumor node metastasis (TNM) stage, acting as an independent prognostic factor of poor survival in patients with HCC. Ectopic expression of miR-942-3p enhanced the proliferation and invasive potential of HCC cells, but inhibition of miR-942-3p expression had the opposite effects. Mannose-binding lectin 2 (MBL2) was further identified as a direct target of miR-942-3p and possessed a negative correlation with miR-942-3p expression and unfavorable survival in patients with HCC. Restoration of MBL2 inhibited the progression of HCC cells and attenuated the tumor-promoting effects induced by miR-942-3p. In conclusion, miR-942-3p may act as an oncogenic factor in HCC cells by targeting MBL2 and provide a potential marker for patients with HCC.